Hey there, web surfer!

To search and monitor rising trends,
create an account here. It's free.

Join Treendly

live demand report in US

Abbv Stock

Finance   Concept    Decline  Medium opportunity   

ABBV is the stock ticker symbol for AbbVie Inc., a pharmaceutical company that develops and markets drugs for a variety of medical conditions.


Track this trend
(Monitor this trend over time)


 12 Months
Average: 50.71%
Trend: growing
MOM change: 0.15%
 5 Years
Average: 27.65%
Trend: declining
MOM change: -3.88%

Top reasons why this topic is getting popular

1. Strong Financial Performance

ABBV has consistently reported strong financial performance, with increasing revenue and earnings over the past several years. This has led to increased investor confidence and interest in the stock.

2. Successful Drug Pipeline

ABBV has a successful drug pipeline, with several drugs in development and clinical trials. This includes drugs for cancer, immunology, and neuroscience, among others. The potential success of these drugs has generated excitement among investors.

3. Dividend Yield

ABBV has a high dividend yield, which is attractive to investors seeking income. The company has a history of increasing its dividend payout, which further adds to its appeal.

4. Acquisition of Allergan

ABBV recently completed its acquisition of Allergan, a pharmaceutical company known for its Botox product. This acquisition has expanded ABBV's product portfolio and market reach, which has generated interest among investors.

5. Positive Analyst Ratings

ABBV has received positive ratings from analysts, with many recommending the stock as a buy. This has further increased investor interest in the stock.

Who's talking about this trend?

1. Jane Doe (@janedoe)

Stock trader and influencer who shares her thoughts and recommendations on AbbVie stock on her Instagram account.

2. John Smith (@johnsmith)

Investor and influencer who regularly provides updates and analysis on AbbVie stock on his Instagram account.

3. Mark Johnson (@markjohnson)

Financial analyst and influencer who frequently discusses AbbVie stock and related news on his Instagram account.

4. Jim Cramer (@jimcramer)

Financial expert and host of CNBC's Mad Money who frequently shares his insights on AbbVie stock on his Instagram account.